PT - JOURNAL ARTICLE AU - T Schneider AU - T Zippel AU - W Schmidt AU - G Pauli AU - U Wahnschaffe AU - S Chakravarti AU - W Heise AU - E O Riecken AU - M Zeitz AU - R Ullrich TI - Increased immunoglobulin G production by short term cultured duodenal biopsy samples from HIV infected patients AID - 10.1136/gut.42.3.357 DP - 1998 Mar 01 TA - Gut PG - 357--361 VI - 42 IP - 3 4099 - http://gut.bmj.com/content/42/3/357.short 4100 - http://gut.bmj.com/content/42/3/357.full SO - Gut1998 Mar 01; 42 AB - Background—Secretory immunity is a major defence mechanism against infections at mucosal surfaces which are common in HIV infected patients. Aims—To analyse intestinal immunoglobulin production in HIV infection in comparison with that in saliva and serum. Patients and methods—Immunoglobulin G (IgG), A (IgA), and M (IgM) concentrations were determined in supernatants of short term cultured duodenal biopsy samples, serum, and saliva from HIV infected patients (n = 28) and controls (n = 14) by radial immunodiffusion. Results—IgG was increased in the supernatants of short term cultured biopsy samples and saliva from HIV infected patients compared with controls (p<0.01), but IgA and IgM levels were normal. In contrast, both IgG and IgA concentrations in serum were higher in HIV infected patients than in controls (p<0.002). No correlation was found between IgA produced by duodenal biopsy specimens and serum IgA. Conclusion—Abnormalities in mucosal immunoglobulin production in HIV infection were suprisingly small, indicating that specific secretory immunity rather than quantitative immunoglobulin production may be impaired. However, increased production of IgG could contribute to mucosal inflammation by complement activation. Our findings of normal mucosal IgA production and the lack of correlation between serum and mucosal IgA argues against an intestinal origin for the increased serum IgA levels in HIV infected patients.